Back

Lowering the neutrophil to lymphocyte ratio by the BET inhibitor, apabetalone: potential implications for cardiovascular events in high risk patients

27 August 2017 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 2 - Coronary artery disease: from bench to bedside Inflammation and microcirculation ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Jan Johansson

Resverlogix Inc., San Francisco (United States of America)

71 More presentations in this session

Presentation thumbnail
Doctor G. Chi (Boston, US)
Abstract Slides
Presentation thumbnail
Professor P. Pignatelli Spinazzola (Rome, IT)
Abstract Slides
Presentation thumbnail
Doctor B. Mahmoodi (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Professor L. Rallidis (Athens, GR)
Abstract Slides
Presentation thumbnail
Doctor J. Adjedj (Saint Laurent du Var, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Coronary artery disease: from bench to bedside

The Event

Event poster

ESC Congress 2017

27 August 2017 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources